Feedforward Artificial Neural Network-Based Colorectal Cancer Detection Using Hyperspectral Imaging: A Step towards Automatic Optical Biopsy.
Source check: Source checked. Not independent scientific confirmation.
Finding: The study included 54 consecutive surgical patients; leave-one-patient-out evaluation reported 86% sensitivity and 95% specificity for cancer/adenoma distinction. The cohort is small and the result is a diagnostic feasibility study; prospective external clinical performance is not established.
Technology: A four-layer feedforward neural network classified hyperspectral tissue annotations to distinguish colorectal cancer, adenoma and healthy samples.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- A four-layer feedforward neural network classified hyperspectral tissue annotations to distinguish colorectal cancer, adenoma and healthy samples.
- Test and result
- The study included 54 consecutive surgical patients; leave-one-patient-out evaluation reported 86% sensitivity and 95% specificity for cancer/adenoma distinction.
- Limitation / still unknown
- The cohort is small and the result is a diagnostic feasibility study; prospective external clinical performance is not established.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://europepmc.org/articles/PMC7956537
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.